These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2473822)

  • 1. Androgen and oestrogen receptor status in benign and neoplastic prostate disease. Study of prevalence and influence on time to progression and survival in prostate cancer treated by hormone manipulation.
    Emtage LA; Dunn PJ; Rowse AD
    Br J Urol; 1989 Jun; 63(6):627-33. PubMed ID: 2473822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preliminary report on the measurement of cytosolic and nuclear prostatic tissue steroid receptors.
    Olsson CA; deVere White R; Goldstein I; Traish AM; Müller RE; Wotiz HH
    Prog Clin Biol Res; 1979; 33():209-21. PubMed ID: 93750
    [No Abstract]   [Full Text] [Related]  

  • 3. Androgen receptor assay in human benign and malignant prostatic tumour cytosol using protamine sulphate precipitation.
    Mobbs BG; Johnson IE; Connolly JG; Clark AF
    J Steroid Biochem; 1978 Apr; 9(4):289-301. PubMed ID: 77938
    [No Abstract]   [Full Text] [Related]  

  • 4. Androgen, estrogen, and progesterone receptor contents and serum hormone profiles in patients with benign hypertrophy and carcinoma of the prostate.
    Kumar VL; Wadhwa SN; Kumar V; Farooq A
    J Surg Oncol; 1990 Jun; 44(2):122-8. PubMed ID: 1693995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study on the concentrations of steroid receptors in adenomatous and cancerous prostatic tissue].
    Rio MC; Offner M
    J Steroid Biochem; 1982 Oct; 17(4):435-41. PubMed ID: 6182395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid receptor and biochemical profiles in prostatic cancer: correlation with response to hormonal treatment.
    Barrack ER; Brendler CB; Walsh PC
    Prog Clin Biol Res; 1987; 243A():79-97. PubMed ID: 3309976
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoreactive EGF in human benign prostatic hyperplasia: relationships with androgen and estrogen receptors.
    Lubrano C; Sciarra F; Spera G; Petrangeli E; Toscano V; Rombola N; Palleschi F; Palma E; Di Silverio F
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):683-7. PubMed ID: 1373303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Androgen, progestin and estrogen receptors in the normal human prostate and in pathology].
    Gerasimova TsI; Smirnov AN; Rozen VB; Buniatian AF; Bol'shakova TD
    Sov Med; 1984; (6):32-6. PubMed ID: 6205454
    [No Abstract]   [Full Text] [Related]  

  • 9. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
    Trachtenberg J; Hicks LL; Walsh PC
    J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranuclear distribution of androgen receptors in human prostate carcinoma.
    Kyprianou N; Gingell JC; Davies P
    J Endocrinol; 1987 Jan; 112(1):161-9. PubMed ID: 2434593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between prostatic cytoplasmic and nuclear androgen receptors in patients with carcinoma of the prostate.
    Ghanadian R; Auf G; Williams G
    Eur Urol; 1981; 7(1):39-40. PubMed ID: 6161820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the R-3327H rat prostatic adenocarcinoma to human benign prostatic hyperplasia and metastatic carcinoma of the prostate with regard to steroid hormone receptors.
    Dahlberg E; Snochowski M; Gustafsson JA
    Prostate; 1980; 1(1):61-70. PubMed ID: 6169071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the association between blood prolactin and androgen receptors in BPH.
    Odoma S; Chisholm GD; Nicol K; Habib FK
    J Urol; 1985 Apr; 133(4):717-20. PubMed ID: 2580105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid receptors in human prostatic cancer a preliminary evaluation.
    de Voogt HJ; Dingjan P
    Urol Res; 1978; 6(3):151-8. PubMed ID: 81556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone receptors in human prostate cancer.
    Blankenstein MA; Bolt-de Vries J; van Aubel OG; van Steenbrugge GJ
    Scand J Urol Nephrol Suppl; 1988; 107():39-45. PubMed ID: 3287596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytoplasmic androgen and estrogen receptor content in the tissues of human prostatic cancer].
    Kushlinskiĭ NE; Bassalyk LS; Matveeva BP; Gorilovskiĭ LM; Degtiar' VG
    Urol Nefrol (Mosk); 1984; (4):41-6. PubMed ID: 6474626
    [No Abstract]   [Full Text] [Related]  

  • 17. A critical evaluation of the use of androgen receptor assays to predict the androgen responsiveness of prostatic cancer.
    Barrack ER; Tindall DJ
    Prog Clin Biol Res; 1987; 239():155-87. PubMed ID: 3309954
    [No Abstract]   [Full Text] [Related]  

  • 18. The binding of a potent synthetic androgen--methyltrienolone (R 1881)--to cytosol preparations of human prostatic cancer.
    Walsh PC; Greco JM; Tananis CE; Hicks LL; McLoughlin MG; Menon M
    Trans Am Assoc Genitourin Surg; 1977; 69():78-80. PubMed ID: 84428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between androgen and estrogen receptors and clinico-morphological characteristics of prostatic cancer].
    Bassalyk LS; Petrova AS; Ermilova VD; Sokolova VK; Kushlinskiĭ NE
    Arkh Patol; 1983; 45(2):23-8. PubMed ID: 6847409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptors and clinical correlations with human prostatic disease.
    Pontes JE; Karr JP; Kirdani RY; Murphy GP; Sandberg AA
    Urology; 1982 Apr; 19(4):399-403. PubMed ID: 6176061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.